Nutra Pharma Corp (NPHC)

[Nagawisdom]

Ida Ho, of course, is correct. The cobra story carried these shares upwards twice. Neither rise was sustainable, because of the uncertainty regarding efficacy. These products now need to work. Unfortunately, in my practice, I have found that people react as they once did to George Bush. People were not neutral or uncertain or complimentary: they were disappointed, profusely abusive of the product and vocal.
Nyloxin, of course, has the potential to turn things around.
Cobroxin fizzled, because, as Ida Ho said: XCHO failed to properly plan and execute a complementary plan of ship and advertise.
The big threat to shareholders here, and it's real is any announcement by any chain that they are dropping the product. Competition for shelf space is fierce. Walmart is now overflowing and highlighting new pain killers for $4.00! But competition everywhere is heightened, because people are a little short of cash.
NPHC must rush to market with Nyloxin. It must clarify the various varieties and should borrow money to advertise, heavily. Strike, while the path to success is still relatively clear.